应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SION Sionna Therapeutics
未开盘 07-09 16:00:00 EDT
20.93
-0.64
-2.97%
盘后
20.93
+0.00
0.00%
16:34 EDT
最高
21.87
最低
20.78
成交量
16.92万
今开
21.87
昨收
21.57
日振幅
5.05%
总市值
9.23亿
流通市值
2.34亿
总股本
4,409万
成交额
359.62万
换手率
1.52%
流通股本
1,116万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Sionna Therapeutics, Inc.2025财年第一财季实现净利润-16.48百万美元,同比减少39.07%
市场透视 · 05-18
Sionna Therapeutics, Inc.2025财年第一财季实现净利润-16.48百万美元,同比减少39.07%
Sionna Therapeutics(SION.US)获Stifel首次覆盖,给予买入评级, 目标价32.00美元。
金融界 · 03-04
Sionna Therapeutics(SION.US)获Stifel首次覆盖,给予买入评级, 目标价32.00美元。
异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高
异动解读 · 02-07
异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高
加载更多
公司概况
公司名称:
Sionna Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sionna Therapeutics, Inc.于2019年8月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,其使命是通过开发使囊性纤维化跨膜电导调节蛋白功能正常化的新药,为CF患者提供具有临床意义的益处,从而彻底改变目前囊性纤维化患者的治疗模式。
发行价格:
--
{"stockData":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":20.93,"timestamp":1752091200000,"preClose":21.57,"halted":0,"volume":169229,"hourTrading":{"tag":"盘后","latestPrice":20.93,"preClose":20.93,"latestTime":"16:34 EDT","volume":99,"amount":2071.51,"timestamp":1752093295230},"delay":0,"floatShares":11163004,"shares":44092117,"eps":-6.81129,"marketStatus":"未开盘","change":-0.64,"latestTime":"07-09 16:00:00 EDT","open":21.87,"high":21.87,"low":20.78,"amount":3596192.4030500003,"amplitude":0.050533,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.81129,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752134400000},"marketStatusCode":0,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":21.57,"preHourTrading":{"tag":"盘前","latestPrice":21.57,"preClose":21.57,"latestTime":"08:45 EDT","volume":1,"amount":21.57,"timestamp":1752065142606},"postHourTrading":{"tag":"盘后","latestPrice":20.93,"preClose":20.93,"latestTime":"16:34 EDT","volume":99,"amount":2071.51,"timestamp":1752093295230},"volumeRatio":0.775703},"requestUrl":"/m/hq/s/SION","defaultTab":"news","newsList":[{"id":"2536559484","title":"Sionna Therapeutics, Inc.2025财年第一财季实现净利润-16.48百万美元,同比减少39.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536559484","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536559484?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584039,"startTime":"0","endTime":"0","summary":"5月19日,Sionna Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-16.48百万美元,同比减少39.07%;其中营业收入为0.00美元,每股基本收益为-0.37美元。从资产负债表来看,Sionna Therapeutics, Inc.总负债17.91百万美元,其中短期债务1.12百万美元,资产负债比为0.21,流动比率为0.29。机构评级:截至2025年5月19日,当前有2家机构对Sionna Therapeutics, Inc.目标价做出预测,其中目标均价为38.50美元,其中最低目标价为32.00美元,最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000155a6e3a72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000155a6e3a72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SION"],"gpt_icon":0},{"id":"2517602818","title":"Sionna Therapeutics(SION.US)获Stifel首次覆盖,给予买入评级, 目标价32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517602818","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517602818?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:42","pubTimestamp":1741110163,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics(SION.US)获Stifel首次覆盖,给予买入评级, 目标价32.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05014248524159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SION","LENZ"],"gpt_icon":0},{"id":"1177801026","title":"异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1177801026","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177801026?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:02","pubTimestamp":1738951356,"startTime":"0","endTime":"0","summary":"生物技术公司Sionna Therapeutics今日盘中股价大涨38.89%,引发市场高度关注。\n\n公司今日在纳斯达克交易所成功 IPO,首次公开募股规模扩大至1.91亿美元,发行价为每股18美元。然而当日开盘后,Sionna Therapeutics的股价即飙升至24美元,较发行价飙升33%,充分体现了资本市场对公司的热捧。\n\n作为一家从事治疗囊性纤维化疾病药物研发的生物技术公司,Sionna Therapeutics正在与制药业巨头Vertex公司展开激烈竞争,力图在这一快速增长的市场占据一席之地。分析人士认为,Sionna成功 IPO体现了投资者对其长期前景的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SION"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sionnatx.com","stockEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.2716},{"period":"3month","weight":1.7324},{"period":"6month","weight":0.1628},{"period":"ytd","weight":0.1628}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sionna Therapeutics, Inc.于2019年8月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,其使命是通过开发使囊性纤维化跨膜电导调节蛋白功能正常化的新药,为CF患者提供具有临床意义的益处,从而彻底改变目前囊性纤维化患者的治疗模式。","exchange":"NASDAQ","name":"Sionna Therapeutics","nameEN":"Sionna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sionna Therapeutics(SION)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sionna Therapeutics(SION)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sionna Therapeutics,SION,Sionna Therapeutics股票,Sionna Therapeutics股票老虎,Sionna Therapeutics股票老虎国际,Sionna Therapeutics行情,Sionna Therapeutics股票行情,Sionna Therapeutics股价,Sionna Therapeutics股市,Sionna Therapeutics股票价格,Sionna Therapeutics股票交易,Sionna Therapeutics股票购买,Sionna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sionna Therapeutics(SION)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sionna Therapeutics(SION)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}